Turning Point Benefit Group’s Axogen AXGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
– Sell
-3
Closed -$98 – 157
2025
Q4
$98 Hold
3
– – ﹤0.01% 809
2025
Q3
$53 Buy
+3
New +$44 ﹤0.01% 743

Other funds holding AXGN

Turning Point Benefit Group's AXGN Position: Q1 2026 in Review

Turning Point Benefit Group sold out of Axogen (AXGN) in Q1 2026, closing a stake of 3 shares — an estimated $98 sold.

Turning Point Benefit Group first reported a position in AXGN in Q3 2025 and held it in 2 quarters. The position peaked at $98 in Q4 2025. 222 funds tracked by Wall St. Rank hold AXGN as of Q1 2026.

  • Turning Point Benefit Group reported no remaining Axogen position as of Q1 2026 after selling out during the quarter.
  • Turning Point Benefit Group sold 3 Axogen shares in Q1 2026, an estimated $98.
  • Turning Point Benefit Group first reported a position in Axogen in Q3 2025 and held it in 2 quarters.
  • Turning Point Benefit Group's Axogen position peaked at $98 in Q4 2025.
  • 222 funds tracked by Wall St. Rank held Axogen as of Q1 2026.

Based on Turning Point Benefit Group's 13F filing for Q1 2026, filed 12 May 2026.